Laboratory Corporation of America Holdings (LH) EPS Estimated At $2.40

January 20, 2018 – By Henry Gaston

Laboratory Corporation of America Holdings (LH) EPS Estimated At $2.40
Investors sentiment decreased to 0.9 in Q3 2017. Its down 0.16, from 1.06 in 2017Q2. It is negative, as 41 investors sold Laboratory Corporation of America Holdings shares while 239 reduced holdings. 70 funds opened positions while 181 raised stakes. 91.79 million shares or 1.82% less from 93.49 million shares in 2017Q2 were reported.
Polar Cap Limited Liability Partnership owns 79,100 shares for 0.13% of their portfolio. Burgundy Asset Mgmt accumulated 0.11% or 76,792 shares. 450 are owned by Virtus Invest Advisers Inc. Allen Investment Mgmt Ltd Com accumulated 776,000 shares. Stifel Financial holds 0.03% or 50,904 shares. John G Ullman And Associates accumulated 2,792 shares. White Pine Invest Co holds 2.06% or 25,645 shares. Alpine Woods Capital Investors Limited Liability Company reported 10,200 shares. Moreover, Da Davidson & has 0.02% invested in Laboratory Corporation of America Holdings (NYSE:LH) for 7,949 shares. Caisse De Depot Et Placement Du Quebec reported 0.01% in Laboratory Corporation of America Holdings (NYSE:LH). Bailard reported 0.04% of its portfolio in Laboratory Corporation of America Holdings (NYSE:LH). United Automobile Association, a Texas-based fund reported 39,235 shares. Meag Munich Ergo Kapitalanlagegesellschaft Mbh holds 0.21% of its portfolio in Laboratory Corporation of America Holdings (NYSE:LH) for 33,830 shares. Jennison Llc reported 987,947 shares or 0.15% of all its holdings. Pillar Pacific Mngmt Limited Liability Co holds 27,175 shares.

Since August 1, 2017, it had 0 buys, and 7 insider sales for $14.75 million activity. Dodson Edward T had sold 2,871 shares worth $459,739. On Friday, August 25 the insider EBERTS F SAMUEL III sold $4.89 million. 5,000 Laboratory Corporation of America Holdings (NYSE:LH) shares with value of $800,000 were sold by Uthgenannt Lisa J. Williams R Sanders sold $486,338 worth of stock or 3,100 shares. Gilliland Dwight Gary sold $149,068 worth of stock or 971 shares. Shares for $7.01M were sold by KING DAVID P on Wednesday, September 6.

Analysts expect Laboratory Corporation of America Holdings (NYSE:LH) to report $2.40 EPS on February, 15.They anticipate $0.25 EPS change or 11.63 % from last quarter’s $2.15 EPS. LH’s profit would be $244.32 million giving it 18.17 P/E if the $2.40 EPS is correct. After having $2.46 EPS previously, Laboratory Corporation of America Holdings’s analysts see -2.44 % EPS growth. The stock increased 0.74% or $1.28 during the last trading session, reaching $174.39. About 637,507 shares traded or 3.00% up from the average. Laboratory Corporation of America Holdings (NYSE:LH) has risen 10.51% since January 20, 2017 and is uptrending. It has underperformed by 6.19% the S&P500.

Laboratory Corporation of America Holdings (NYSE:LH) Ratings Coverage

Among 19 analysts covering Laboratory Corp (NYSE:LH), 10 have Buy rating, 0 Sell and 9 Hold. Therefore 53% are positive. Laboratory Corp had 49 analyst reports since July 29, 2015 according to SRatingsIntel. The firm earned “Hold” rating on Tuesday, September 12 by Jefferies. Jefferies maintained Laboratory Corporation of America Holdings (NYSE:LH) on Thursday, October 19 with “Hold” rating. On Thursday, October 12 the stock rating was upgraded by Wells Fargo to “Buy”. On Friday, June 9 the stock rating was maintained by Jefferies with “Hold”. The firm earned “Hold” rating on Wednesday, July 12 by Credit Suisse. The firm earned “Neutral” rating on Friday, September 9 by Citigroup. The rating was maintained by Mizuho with “Neutral” on Friday, February 17. Robert W. Baird maintained it with “Hold” rating and $167.0 target in Friday, September 1 report. The stock has “Neutral” rating by Mizuho on Wednesday, July 29. The firm earned “Neutral” rating on Tuesday, April 26 by UBS.

Laboratory Corporation of America Holdings operates as an independent clinical laboratory firm worldwide. The company has market cap of $17.75 billion. It operates through two divisions, LabCorp Diagnostics and Covance Drug Development. It has a 24.32 P/E ratio. The firm offers a range of clinical laboratory tests and procedures, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C, PSA, tests for sexually-transmitted diseases, HCV tests, vitamin D, microbiology cultures and procedures, and alcohol and other substance-abuse tests that are used by hospitals, physicians and other healthcare providers and commercial clients to assist in the diagnosis, monitoring and treatment of diseases and medical conditions through the examination of substances in blood, tissues, and other specimens.

Another recent and important Laboratory Corporation of America Holdings (NYSE:LH) news was published by Businesswire.com which published an article titled: “LabCorp Named to FORTUNE Magazine’s 2018 List of ‘World’s Most Admired Companies’” on January 19, 2018.

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our daily email newsletter.


Share On Facebook
Share On Twitter
Share On Google Plus
Share On Linkedin
Share On Pinterest
Share On Reddit
Share On Stumbleupon
Loading Facebook Comments ...
0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *